Health Advance Appoints New Executive Managers and Discloses New Events
January 17 2018 - 5:41AM
COLORADO SPRINGS, Colo., Jan. 17, 2018 (GLOBE NEWSWIRE) --
Yesterday Health Advance Inc. (OTC PINK:HADV) filed a Form 8-K
Report, adopting a new Board Resolution to appoint new executive
managers and officers of the Company to take effect
immediately.
The Company has appointed Chairman and Executive Director, Greg
Shusterman as the new Acting President of Health Advance Inc.
Shusterman was appointed as Director and Vice Chairman at Health
Advance in 2017 and was the Acting Chairman and Executive Director
through January 2018. Before joining Health Advance he served as a
consultant to national robotic surgical clinics MiVIP Surgery
Centers and oBand Inc. Additionally, Shusterman was co-founder and
Executive Vice President at Gubagoo Inc., a leading customer
communications solution platform serving thousands of clients
including Ford, Fiat, Chrysler, BMW, Volkswagen, Kia and Land
Rover. His entrepreneurial experience has helped bring start-up
companies through growth and expansion phases, to maturity and
exit.
Furthermore, the Company has appointed Board Director, Christian
Diesveld as Vice President of Investor Relations who will assist
the Company with fund-raising goals. Diesveld previously worked
various senior leadership positions for a number of companies,
including, but not limited to, Hantian Labs Limited, a pending
acquisition of the Company, where Mr. Diesveld was recently named
UK CEO of the Year – Small Enterprise in the Health and Wellness
sector. Additionally, Diesveld brings over twenty years experience
in capital markets, specializing in private equity and venture
capital with FCA licensed firms. Diesveld attended York University
where he majored in International Business and worked at Nesbitt
Burns as an Investment Advisor.
Micro Medtech Ltd. remains active with the Company under a license
agreement, working on developing two patented medical food
formulations derived from NSAID alternatives and botanical extract
blends that contain kava, cannabidiol ("CBD”), and mitragyna
speciosa (better known as kratom)- Med-patents, known as Polyoxyfen
and Cebidiofen. An exhibit from the recent most quarterly report
for the Company filed in December displayed that there are plans
for clinical trials and a medical research program titled
KLEAN beginning early this year at a government accredited
medical college in Pohnpei, Micronesia.
For more information about Health Advance visit www.hadvinc.com
and www.staycleanmed.com.
Media Relations Contact:
media@hadvinc.com
Phone: 719-466-6699
Health Advance (PK) (USOTC:HADV)
Historical Stock Chart
From Sep 2024 to Oct 2024
Health Advance (PK) (USOTC:HADV)
Historical Stock Chart
From Oct 2023 to Oct 2024
